We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

461 hedge funds and large institutions have $9.45B invested in United Therapeutics in 2022 Q3 according to their latest regulatory filings, with 54 funds opening new positions, 170 increasing their positions, 160 reducing their positions, and 61 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more call options, than puts

Call options by funds: $104M | Put options by funds: $51M

2.74% more ownership

Funds ownership: 97.2% → 99.94% (+2.7%)

6% more repeat investments, than reductions

Existing positions increased: 170 | Existing positions reduced: 160

2% less funds holding

Funds holding: 472 → 461 (-11)

9% less capital invested

Capital invested by funds: $10.3B → $9.45B (-$878M)

11% less first-time investments, than exits

New positions opened: 54 | Existing positions closed: 61

25% less funds holding in top 10

Funds holding in top 10: 24 → 18 (-6)

Holders
461
Holders Change
-11
Holders Change %
-2.33%
% of All Funds
7.94%
Holding in Top 10
18
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-25%
% of All Funds
0.31%
New
54
Increased
170
Reduced
160
Closed
61
Calls
$104M
Puts
$51M
Net Calls
+$53.1M
Net Calls Change
+$3.64M

Top Buyers

1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$211M
2
Citadel Advisors
Citadel Advisors
Florida
+$124M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$63.7M
4
APM
Avidity Partners Management
Texas
+$54.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$36.6M

Top Sellers

1
Renaissance Technologies
Renaissance Technologies
New York
-$54.4M
2
PAMS
Pictet Asset Management (Switzerland)
Switzerland
-$41.7M
3
Bank of New York Mellon
Bank of New York Mellon
New York
-$39M
4
American Century Companies
American Century Companies
Missouri
-$36.1M
5
First Trust Advisors
First Trust Advisors
Illinois
-$35.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
101
State of Wisconsin Investment Board
Wisconsin
$11.4M +$242K +1,084 +2%
ACM
102
Atika Capital Management
New York
$11.1M -$1.34M -6,000 -10%
TD Asset Management
103
TD Asset Management
Ontario, Canada
$10.9M -$1.03M -4,628 -8%
Envestnet Asset Management
104
Envestnet Asset Management
Illinois
$10.5M -$111K -496 -1%
Los Angeles Capital Management
105
Los Angeles Capital Management
California
$10.2M +$10.9M +48,812 New
Axa
106
Axa
France
$10.2M +$986K +4,412 +10%
LOAMS
107
Lombard Odier Asset Management (Switzerland)
Switzerland
$10M -$4.09M -18,297 -28%
State Board of Administration of Florida Retirement System
108
State Board of Administration of Florida Retirement System
Florida
$9.94M -$264K -1,180 -2%
Two Sigma Advisers
109
Two Sigma Advisers
New York
$9.44M +$201K +900 +2%
SCM
110
Sio Capital Management
New York
$9.41M +$1.12M +5,000 +13%
TRSOTSOK
111
Teachers Retirement System of the State of Kentucky
Kentucky
$9.38M +$10M +44,816 New
BC
112
Brahman Capital
New York
$9.32M +$3.88M +17,359 +64%
BA
113
Bridgewater Associates
Connecticut
$9.26M -$2.28M -10,209 -19%
SEI Investments
114
SEI Investments
Pennsylvania
$9.21M -$5.27M -23,581 -35%
RJA
115
Raymond James & Associates
Florida
$8.89M -$1.21M -5,425 -11%
UBS Group
116
UBS Group
Switzerland
$8.81M -$5.74M -25,694 -38%
T
117
TOBAM
France
$8.69M +$8.44M +37,750 +1,002%
WC
118
Weil Company
California
$8.47M +$665K +2,974 +8%
CS
119
Credit Suisse
Switzerland
$8.02M +$259K +1,157 +3%
DCM
120
Driehaus Capital Management
Illinois
$7.94M -$1.53M -6,841 -15%
Manulife (Manufacturers Life Insurance)
121
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$7.72M -$1.04M -4,650 -11%
D.E. Shaw & Co
122
D.E. Shaw & Co
New York
$7.71M -$11.4M -50,832 -58%
MOACM
123
Mutual of America Capital Management
New York
$7.66M -$295K -1,318 -3%
OAM
124
Oppenheimer Asset Management
New York
$7.2M -$118K -527 -2%
SCP
125
Seizert Capital Partners
Michigan
$7.16M -$104K -463 -1%
3 4
5
6 7

UTHR Hedge Fund Activity: Q3 2022 in Review

461 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q3 2022, worth a combined $9.45B — down 8.5% from $10.3B a quarter earlier.

Sellers outnumbered buyers: 61 funds closed out of UTHR and 54 opened new positions — a net loss of 7 holders — while 160 trimmed existing stakes and 170 added.

The largest buyer was Janus Henderson Group, adding an estimated $211M. The largest seller was Renaissance Technologies, cutting an estimated $54.4M.

  • 461 institutional investors held United Therapeutics (UTHR) as of Q3 2022, down from 472 in Q2 2022.
  • Funds reported $9.45B of United Therapeutics stock for Q3 2022, down 8.5% quarter-over-quarter.
  • 54 funds opened new United Therapeutics positions in Q3 2022 and 61 closed out, a net change of -7 holders.
  • The largest United Therapeutics buyer in Q3 2022 was Janus Henderson Group, an estimated $211M added.
  • The largest United Therapeutics seller in Q3 2022 was Renaissance Technologies, an estimated $54.4M sold.

Based on aggregated 13F filings for Q3 2022.